ID
42567
Description
Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00824668
Link
https://clinicaltrials.gov/show/NCT00824668
Keywords
Versions (2)
- 3/10/18 3/10/18 -
- 9/2/21 9/2/21 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
September 2, 2021
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Diabetes NCT00824668
Eligibility Diabetes NCT00824668
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Antidiabetics Oral
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0935929
- UMLS CUI [1,2]
- C1527415
Description
Heart Diseases | Chronic heart failure New York Heart Association Classification | Angina, Unstable | Myocardial Infarction Treated | Myocardial Infarction untreated
Data type
boolean
Alias
- UMLS CUI [1]
- C0018799
- UMLS CUI [2,1]
- C0264716
- UMLS CUI [2,2]
- C1275491
- UMLS CUI [3]
- C0002965
- UMLS CUI [4,1]
- C0027051
- UMLS CUI [4,2]
- C1522326
- UMLS CUI [5,1]
- C0027051
- UMLS CUI [5,2]
- C0332155
Description
Hepatic Insufficiency | Alanine aminotransferase increased | Aspartate aminotransferase increased
Data type
boolean
Alias
- UMLS CUI [1]
- C1306571
- UMLS CUI [2]
- C0151905
- UMLS CUI [3]
- C0151904
Description
Renal Insufficiency | Creatinine measurement, serum | Gender
Data type
boolean
Alias
- UMLS CUI [1]
- C1565489
- UMLS CUI [2]
- C0201976
- UMLS CUI [3]
- C0079399
Description
Recurrent hypoglycemia
Data type
boolean
Alias
- UMLS CUI [1]
- C1846288
Description
Anemia | Hemoglobin measurement | Gender
Data type
boolean
Alias
- UMLS CUI [1]
- C0002871
- UMLS CUI [2]
- C0518015
- UMLS CUI [3]
- C0079399
Description
Pharmaceutical Preparations Changing Glucose metabolism | Non-Prescription Drugs Changing Glucose metabolism | Exception Insulin | Glucocorticoids, Systemic | Glucocorticoids Inhalation | Anabolic steroids | Non-selective beta-blocking agent
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0392747
- UMLS CUI [1,3]
- C0596620
- UMLS CUI [2,1]
- C0013231
- UMLS CUI [2,2]
- C0392747
- UMLS CUI [2,3]
- C0596620
- UMLS CUI [3,1]
- C1705847
- UMLS CUI [3,2]
- C0021641
- UMLS CUI [4]
- C3540777
- UMLS CUI [5,1]
- C0017710
- UMLS CUI [5,2]
- C0205535
- UMLS CUI [6]
- C0002845
- UMLS CUI [7]
- C0304515
Similar models
Eligibility Diabetes NCT00824668
- StudyEvent: Eligibility
C0872146 (UMLS CUI [1,2])
C0456683 (UMLS CUI [1,2])
C1527415 (UMLS CUI [1,2])
C0264716 (UMLS CUI [2,1])
C1275491 (UMLS CUI [2,2])
C0002965 (UMLS CUI [3])
C0027051 (UMLS CUI [4,1])
C1522326 (UMLS CUI [4,2])
C0027051 (UMLS CUI [5,1])
C0332155 (UMLS CUI [5,2])
C0151905 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
C0201976 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
C0518015 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
C0392747 (UMLS CUI [1,2])
C0596620 (UMLS CUI [1,3])
C0013231 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
C0596620 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0021641 (UMLS CUI [3,2])
C3540777 (UMLS CUI [4])
C0017710 (UMLS CUI [5,1])
C0205535 (UMLS CUI [5,2])
C0002845 (UMLS CUI [6])
C0304515 (UMLS CUI [7])